News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Investing.com Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Hims & Hers Health, Inc. (NASDAQ:HIMS) Director Kare Schultz was granted 8,223 Restricted Stock Units (RSUs) on August 12, 2026, as disclosed in a Form 4 filed with the SEC on August 14, 2026. These RSUs were granted at no cost and will vest …
Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 6% in extended trading on August 10 after the telehealth company delivered another quarter of rapid growth alongside sharply weaker profitability. Revenue rose 38% year over year to $753.2 million, subscribers increased 19% to 2.89 …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Kaplan Fox & Kilsheimer LLP is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities law violations. This investigation follows a lawsuit filed by the FTC and California/Utah authorities alleging that Hims & Hers failed to clearly disclose prescription charges, made it …
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q2 CY2026, with sales up 38.2% year on year to $753.2 million. On top of that, next quarter's revenue guidance ($890 …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%The Federal Trade Commission, alongside the State of California and Utah Division of Consumer Protection, has filed a lawsuit against Hims & Hers Health Inc. The lawsuit alleges that Hims & Hers misled consumers by charging them for prescription medication subscriptions they never agreed …
A new class action lawsuit has been filed against Hims & Hers Health Inc., alleging that the telehealth company secretly shared sensitive patient health data and identifying details with advertising and analytics firms like Meta, Google, and Snap without consent. The lawsuit claims that …
Hims stock toppled Tuesday. Analysts are watching the telehealth giant's move closer to the peptide segment. Continue Reading
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Hims & Hers Health, Inc. reported second-quarter 2026 sales of US$753.21 million, up from US$544.83 million a year earlier, but moved from net income of US$42.51 million to a net loss of US$86.29 million, while also raising full-year 2026 revenue guidance to between US$3.10 …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%What happened: Hims & Hers Health (HIMS) stock declined 3% before trimming losses on Tuesday. What's behind the move: Shares were volatile after the telehealth company swung to a loss of $0.37 per share in the second quarter from a profit of $0.17 a …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Hims & Hers Q2 revenue beat offset by wider-than-expected loss Proactive uses images sourced from Shutterstock Hims & Hers Health (NYSE:HIMS) delivered mixed second-quarter results, with revenue beating Wall Street expectations while its quarterly loss came in wider than analysts had forecast as the …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Lowey Dannenberg, P.C. has filed a class action complaint against Hims & Hers Health, Inc., alleging the company misrepresented privacy and shared sensitive health information without consent. This complaint follows a civil enforcement action by the FTC and other state bodies against Hims & …
This article first appeared on GuruFocus. Hims & Hers Health, Inc. (NYSE:HIMS) fell 6.11% in premarket after reporting second-quarter revenue of $753.2 million, up 38% year over year and above the $699 million analysts estimate. The company added 452,000 subscribers during the past year, …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%This article first appeared on GuruFocus. Hims & Hers Health Inc. (HIMS, Financials) the digital health platform, boosted its full-year revenue outlook after another quarter of robust growth, but investors are also getting a better sense of what that expansion will cost. Warning! GuruFocus …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Hims & Hers Health Earnings: What To Look For From HIMS Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here's what to expect. Hims & Hers Health missed analysts' revenue expectations last quarter, reporting revenues …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Hims & Hers Health reported a net loss of $86.3 million in the second quarter of 2026, swinging from net income of $42.5 million in the same period a year earlier, even as revenue climbed 38% to $753.2 million. The company raised its full-year …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%The article analyzes Hims & Hers Health Inc. (HIMS) using AI models to identify technical signals and institutional trading strategies. It highlights a near-term strong sentiment for HIMS that could challenge persistent mid and long-term weakness, noting resistance testing and a significant risk-reward short …
Earnings Call Insights: Hims & Hers Health (HIMS) Q2 2026 MANAGEMENT VIEW * "In the second quarter, we welcomed more than 300,000 subscribers, bringing our global subscriber base to nearly 3 million people." (Co-Founder, Chairman & CEO Andrew Dudum) * "In June, we became …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%This article first appeared on GuruFocus. Revenue: Grew nearly 40% year-over-year to more than $753 million in the second quarter. Subscribers: Added 300,000 net new subscribers, ending the quarter with nearly 3 million. Domestic Revenue: Accelerated to 16% year-over-year growth, generating $622 million. International …
Sharemaestro market context Trend signal active 52 weeks -41.8% · Next-week setup negative 38.1%Search by ticker symbol or company name and select a result to open its chart.